Sign in

CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company

TriSalus Life Sciences, Inc.

Sign in to watch
Ticker
TLSI
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853009869
Phone
415 336 8917
Business address
6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
Former names
MedTech Acquisition Corp, MedTech Acquisition Corporation

Securities

  • TLSI Common Stock Nasdaq
  • TLSIW Warrant Nasdaq
  1. 4 Grant or award Chief Commercial Officer acquired 12,500 shares (grant or award)
  2. 4 Grant or award CHIEF REGULATORY OFFICER acquired 10,625 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Director acquired 10,040 shares (grant or award)
  5. 4 Grant or award Director acquired 10,040 shares (grant or award)
  6. 4 Open-market sale CHIEF SCIENTIFIC & MANUFACT. sold 314 shares at $4.44 ($1,394)
  7. 4 Grant or award Director acquired 25,188 shares (grant or award)
  8. 4 Open-market buy 10% owner bought 62,972 shares at $3.97 ($249,999)
  9. 4 Open-market sale Director sold 30,000 shares at $3.69 ($110,700)
  10. 4 Open-market buy Director bought 5,000 shares at $4.55 ($22,750)
  11. 4 Open-market buy Director bought 10,727 shares at an average $4.39 ($47,057)
  12. 4 Grant or award SR.VP, CORP. DEV. & STRATEGY acquired 6,875 shares (grant or award)
  13. 4 Open-market buy CEO AND PRESIDENT bought 14,815 shares at an average $5.09 ($75,359)
  14. 4 Open-market buy CEO AND PRESIDENT bought 5,000 shares at $4.97 ($24,850)
  15. 4 Open-market sale Director sold 9 shares at $5.50 ($50)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 9 · 163 filings